Increased autocrine interleukin‐6 production is significantly associated with worse clinical outcome in patients with chronic lymphocytic leukemia

Chronic lymphocytic leukemia (CLL) remains incurable with current standard therapy. We have previously reported that an increased expression of interleukin‐6 (IL‐6) receptor CD126 leads to resistance of CLL cells to chemotherapy and worse prognosis for patients with CLL. In this study, we determine...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hua‐Qing, Jia, Li, Li, Yu‐Ting, Farren, Timothy, Agrawal, Samir G., Liu, Feng‐Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590298/
https://www.ncbi.nlm.nih.gov/pubmed/30623437
http://dx.doi.org/10.1002/jcp.28086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590298/
https://www.ncbi.nlm.nih.gov/pubmed/30623437
http://dx.doi.org/10.1002/jcp.28086

Ejemplares similares